CNS Pharmaceuticals Inc.

CNSP | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.24

+$0.02 (+0.41%)

At close: Sep 22, 2026, 4:00 PM ET

$5.12

-$0.12 (-2.29%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $7.63M

Enterprise Value $-12.36M

Beta 1.00

Average Volume 1.43M

Shares Outstanding (Diluted) 6.84M

Shares Change YoY 1747.52%

Institutional Ownership 2.13%

Exchange NASDAQ

ISIN US18978H5081

Price Performance

Price Change 1M -8.4%

Price Change 3M 21.7%

Price Change 6M 91.2%

Price Change YTD -1.5%

Price Change 1Y -38.4%

Price Change 3Y -100.0%

Price Change 5Y -100.0%

1M CAGR (ann.) -3.0%

1Y CAGR (ann.) -40.3%

5Y CAGR (ann.) -91.8%

All-Time CAGR -86.1%

Valuation

PE Ratio -0.22

Forward PE N/A

PEG Ratio -0.00

Forward PEG -0.37

PS Ratio N/A

Forward PS 0.20

PB Ratio 0.42

P/FCF Ratio -0.57

P/Adj. FCF Ratio -0.56

P/OCF Ratio -2.66

EV/Sales N/A

EV/EBIT 0.74

EV/EBITDA 0.74

EV/FCF 0.92

Earnings Yield -451.9%

FCF Yield -176.3%

Adj. FCF Yield -177.7%

Financial Health

Net Cash $19.99M

Total Debt $0

Cash & Short-Term Investments $19.99M

Total Assets $21.94M

Current Ratio 5.86

Quick Ratio 5.86

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage -1,131.57

Altman Z-Score -7.17

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -0.8%

Returns

Return on Assets -76.1%

Return on Equity -204.3%

Return on Invested Capital -92.9%

Return on Capital Employed -92.9%

Return on Tangible Assets -76.1%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 149.5%

EPS CAGR 5Y 92.0%

EPS CAGR 10Y N/A

FCF CAGR 3Y -8.9%

FCF CAGR 5Y -8.7%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 4

EPS Growth Next 3Y 30.5%

Revenue Growth Next 3Y N/A

Earnings Date Nov 17, 2026

EPS Estimate (next Q) -$0.27

EPS Growth Est (next Q) -95.3%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $0.50

Price Target Upside -90.4%

Cash Flow

Operating Cash Flow $-13.41M

Free Cash Flow $-13.44M

Adj. Free Cash Flow $-13.55M

FCF Per Share -$1.97

OCF Per Share -$1.96

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $333

Operating Income $-16.91M

EBITDA $-16.65M

Net Income $-16.7M

EPS (Diluted) -$23.59

Revenue / Employee N/A

Profit / Employee $-2.09M

Employees 8